
    
      It is a prospective double blinded controlled study that will be carried out on 60 pediatric
      patients undergoing GIT endoscopy; they will be divided into two groups of 30 patients each:-
      Group I (PF): will receive 0.5 Âµg/ kg fentanyl + 2 mg/ kg propofol IV. Group II (KF): will
      receive Ketofol (1 ketamine: 4 propofol) 0.5 mg/kg ketamine + 2 mg/kg propofol IV.
    
  